Who owns SENSEI BIOTHERAPEUTICS INC?
- Ticker: SNSE
- CUSIP Number: 81728a108
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold SENSEI BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Newtyn Management | 930k | $977k | -41% | Mar 2024 |
|
| Vanguard Group | 574k | $603k | 0% | Mar 2024 |
|
| Geode Capital Management | 136k | $143k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 113k | $119k | 0% | Mar 2024 |
|
| Bank of America Corporation | 91k | $95k | 0% | Mar 2024 |
|
| BlackRock | 34k | $35k | -5% | Mar 2024 |
|
| Millennium Management | 33k | $34k | -15% | Mar 2024 |
|
| Northern Trust | 26k | $27k | 0% | Mar 2024 |
|
| Citadel Advisors | 24k | $25k | -8% | Mar 2024 |
|
| Two Sigma Advisers | 19k | $20k | 0% | Mar 2024 |
|
| Leo Wealth | 15k | $16k | 0% | Mar 2024 |
|
| Raymond James & Associates | 14k | $15k | 0% | Mar 2024 |
|
| Morgan Stanley | 12k | $13k | 5479% | Mar 2024 |
|
| Deuterium Capital Management | 11k | $12k | 0% | Mar 2024 |
|
| Two Sigma Investments | 10k | $11k | 0% | Mar 2024 |
|
| Tower Research Capital | 6.7k | $7.0k | -8% | Mar 2024 |
|
| Banque Cantonale Vaudoise | 3.9k | $4.0k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 668.00 | $700.999200 | 0% | Mar 2024 |
|
| UBS Group | 139.00 | $146.005600 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 133.00 | $139.995800 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 53.00 | $0 | -90% | Mar 2024 |
|
| Qube Research & Technologies | 4.00 | $4.000000 | 0% | Mar 2024 |
|
Who sold out of Sensei Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Duquesne Family Office | Dec 2023 | 100k | $69k |